Amines and amides for the treatment of diseases

Details for Australian Patent Application No. 2005216955 (hide)

Owner La Jolla Pharmaceutical Company

Inventors MacDonald, Mary T.; Zhao, Jingjing; Wang, Eric Y.; Salter-Cid, Luisa Maria

Agent FB Rice

Pub. Number AU-A-2005216955

PCT Pub. Number WO2005/082343

Priority 60/619,159 15.10.04 US; 60/569,017 06.05.04 US; 60/601,221 13.08.04 US; 60/547,997 25.02.04 US

Filing date 25 February 2005

Wipo publication date 9 September 2005

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/437 (2006.01)

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082343 Priority application(s): WO2005/082343

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216956-Multi-bit ADC with sigma-delta modulation

2005216954-Heat stabilized sub-stoichiometric dielectrics